Feb 08, 2017 13:03 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Feb. 08, 2017 -- Portola Pharmaceuticals, Inc.® (Nasdaq:PTLA) today announced that the U.S. Food and Drug Administration (FDA)’s Center for Drug Evaluation and Research (CDER) has informed...
361 Managed Futures Strategy Fund Receives Top Morningstar Rating
Feb 08, 2017 13:03 pm UTC| Business
DENVER, Feb. 08, 2017 -- 361 Capital, a leading boutique asset manager offering distinctive investment strategies to institutions, investment advisors and their clients, today announced its 361 Managed Futures Strategy...
Feb 08, 2017 13:03 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Feb. 08, 2017 -- Portola Pharmaceuticals, Inc.® (Nasdaq:PTLA) today announced that the U.S. Food and Drug Administration (FDA)’s Center for Drug Evaluation and Research (CDER) has informed...
Feb 08, 2017 13:03 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Feb. 08, 2017 -- Portola Pharmaceuticals, Inc.® (Nasdaq:PTLA) today announced that the U.S. Food and Drug Administration (FDA)’s Center for Drug Evaluation and Research (CDER) has informed...
OMA Calls Ordinary Shareholders’ Meeting
Feb 08, 2017 13:03 pm UTC| Business
MONTERREY, Mexico, Feb. 08, 2017 -- Mexican airport operator Grupo Aeroportuario del Centro Norte, S.A.B. de C.V., known as OMA (NASDAQ:OMAB) (BMV:OMA), today published a call for an Ordinary Shareholders’ Meeting to be...
Feb 08, 2017 13:03 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Feb. 08, 2017 -- Portola Pharmaceuticals, Inc.® (Nasdaq:PTLA) today announced that the U.S. Food and Drug Administration (FDA)’s Center for Drug Evaluation and Research (CDER) has informed...
OMA Calls Ordinary Shareholders’ Meeting
Feb 08, 2017 13:03 pm UTC| Business
MONTERREY, Mexico, Feb. 08, 2017 -- Mexican airport operator Grupo Aeroportuario del Centro Norte, S.A.B. de C.V., known as OMA (NASDAQ:OMAB) (BMV:OMA), today published a call for an Ordinary Shareholders’ Meeting to be...